Preventing β-Cell Loss and Diabetes With Calcium Channel Blockers

Although loss of functional β-cell mass is a hallmark of diabetes, no treatment approaches that halt this process are currently available. We recently identified thioredoxin-interacting protein (TXNIP) as an attractive target in this regard. Glucose and diabetes upregulate β-cell TXNIP expression, a...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Guanlan, Chen, Junqin, Jing, Gu, Shalev, Anath
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2012
Materias:
Islet Studies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3314354/
https://www.ncbi.nlm.nih.gov/pubmed/22442301
http://dx.doi.org/10.2337/db11-0955

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3314354/
https://www.ncbi.nlm.nih.gov/pubmed/22442301
http://dx.doi.org/10.2337/db11-0955

Ejemplares similares